Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 416475
                    [Title] => Heart specialists welcome ARB trial
                    [Summary] => Local heart specialists welcomed the results of a landmark trial showing that the angiotensin receptor blocker (ARB) telmisartan is as effective as, and better tolerated than, the gold standard angiotensin-converting enzyme (ACE) inhibitor ramipril in reducing the risk of heart attack, stroke and hospitalization for congestive heart failure in high-risk patients.
                    [DatePublished] => 2008-11-20 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

TELMISARTAN ALONE

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 416475
                    [Title] => Heart specialists welcome ARB trial
                    [Summary] => Local heart specialists welcomed the results of a landmark trial showing that the angiotensin receptor blocker (ARB) telmisartan is as effective as, and better tolerated than, the gold standard angiotensin-converting enzyme (ACE) inhibitor ramipril in reducing the risk of heart attack, stroke and hospitalization for congestive heart failure in high-risk patients.
                    [DatePublished] => 2008-11-20 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Heart specialists welcome ARB trial

November 20, 2008 - 12:00am

Local heart specialists welcomed the results of a landmark trial showing that the angiotensin receptor blocker (ARB) telmisartan is as effective as, and better tolerated than, the gold standard angiotensin-converting...

Science and Environment